NCT06111235 A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06092450 Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer Status RECRUITING Phase N/A
NCT06091124 Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma Status RECRUITING Phase PHASE2
NCT06059547 Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06046469 Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder Cancer Status UNKNOWN Phase NA
NCT06040762 A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial Status RECRUITING Phase NA
NCT06034015 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers Status UNKNOWN Phase PHASE1
NCT06032910 Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias Status RECRUITING Phase NA
NCT06026332 ADSTILADRIN Early Utilization and Outcomes in the Real World Setting Status TERMINATED Phase N/A
NCT06022029 A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. Status RECRUITING Phase PHASE1
NCT06020651 Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside Status COMPLETED Phase NA
NCT06009848 Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE2
NCT06009510 Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06002269 A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients Status COMPLETED Phase NA
NCT05982561 Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer Status RECRUITING Phase N/A
NCT05975151 Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE2